ReviewJAC-antimicrobial resistance2025
A rapid literature review of the impact of penicillin allergy on antibiotic resistance.
Review in JAC-antimicrobial resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Parental awareness and management of antibiotic side effects and allergies in children and young people: a UK survey.JAC-antimicrobial resistance · 2026Article
- Widening access to penicillin allergy assessment in the United Kingdom-a proposed implementation plan for the National Health Service (NHS).JAC-antimicrobial resistance · 2026Review
- Nurse-Initiated Improvement for Documentation of Penicillin Adverse Drug Reactions in Pediatric Urgent Care Clinics.Children (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Antimicrobial resistance (AMR) is caused by the use and misuse of antibiotics. AMR is a global health concern, to which penicillin allergy (penA) labels appear to contribute. Patients who have penA labels are treated with non-penicillin antibiotics and receive more antibiotics when compared with patients without penA. Although penA is common, after formal allergy assessments, >90% of people with a penA label are found not to be allergic; therefore, broad-spectrum antibiotics are being misused and overused unnecessarily in these patients. Antimicrobial stewardship policies now advocate assessment to identify and remove incorrect penA labels; however, there is limited evidence on whether rectifying incorrect penA labels results in less AMR. This review aimed to assess the association between AMR and antibiotic allergy labels. Methods: A comprehensive literature search using EMBASE and MEDLINE databases was conducted. Studies were included if they compared the presence of infection or colonization with an antimicrobial-resistant organism in participants with and without antibiotic allergy. Results: Thirty-three studies were included, and all the studies were observational in design and included a variety of patient groups. Eighteen studies compared AMR outcomes in participants with and without penA, and the rest investigated the impact of beta-lactam allergy or any antibiotic allergy on AMR outcomes. MRSA was the most investigated pathogen, and 11 of 13 studies showed that penA was associated with MRSA. PenA labels were also associated with vancomycin-resistant enterococci (three of five studies). There was limited evidence on the impact of penA on extended-spectrum beta-lactamase-producing Enterobacterales and resistant Conclusion: The presence of penA labels is associated with antibiotic resistance in key pathogens in a wide variety of patient groups.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.